Filter articles using the following links

45th NANOS Annual Meeting, Las Vegas, Nevada, US

Oddo BHF Forum, Lyon, France

37th Annual J.P. Morgan Healthcare Conference, San Francisco (CA), USA

World Orphan Drug Congress Europe, Barcelona, Spain

GenSight Biologics enrolls first subject in first-in-man PIONEER Phase I/II clinical trial of GS030 combining gene therapy and Optogenetics for the treatment of Retinitis Pigmentosa

GenSight Biologics Reports its Cash Position as of September 30, 2018

GenSight Biologics reports positive 72-week data from REVERSE Phase III clinical trial of GS010 for the treatment of Leber Hereditary Optic Neuropathy (LHON)

GenSight Biologics to present REVERSE data with GS010 at the 2018 Annual Meeting of the American Academy of Ophthalmology

GenSight Biologics to participate in multiple upcoming investor conferences

Salon Actionaria 2018, Paris, France